Summary Many patients with Stage 1 non-seminomas are now treated by orchidectomy and close follow-up along. Chart review indicated that a group of such patients, compared with patients treated with chemotherapy, tended to be less compliant with follow-up. A questionnaire given to a second sample of patients confirmed that surgical patients underestimated the dangers of the disease and chances of relapse, and doubted the value of follow-up.
In the last two decades developments in diagnostic techniques and chemotherapy for nonseminomatous testicular cancer have resulted in very high cure rates (e.g. Pizzocaro et al., 1986; Sogani et al., 1984) . There is a recent trend towards treating patients with Stage 1 tumours by orchidectomy alone and reserving further treatment for those who relapse (ibid). If relapse is detected soon enough the majority of these patients will be cured by appropriate chemotherapy. Most patients presenting with metastatic disease can also be cured. If relapse occurs after surgery or chemotherapy, it tends to do so generally within 2 years. The risk of relapse is 20-30% for patients treated with surgery alone, compared with less than 10% for those in complete remission after chemotherapy for all but advanced metastatic disease (ibid). Cure is still possible for some patients relapsing after first-line chemotherapy.
It is therefore important that patients in both categories, but particularly those treated by surgery alone, should have regular follow-up with clinical examination, radiological examination, and tumour marker studies as appropriate.
We have observed that patients treated with surgery alone seem to keep follow-up appointments less often than those treated with chemotherapy (Young et al., 1989) . The present study attempts to confirm this observation and to determine by questionnaire the reason for noncompliance.
Patients and methods
An initial chart review sample comprised 25 adult patients with non-seminomas being followed after orchidectomy alone (11 patients) or chemotherapy (14 patients). All patients were followed exclusively at this centre for over a year, had only one primary and were referred within 2 months of orchidectomy. A second sample of 27 patients meeting the above criteria completed a questionnaire.
Chart review
Three compliance measures were derived from charts: (1) The total number of visits made was compared with the total number of appointments and/or investigations booked. Any hospitalisation was counted as one instance of compliance, (2) The number of times the patient was examined or tested at intervals of 6 weeks or less was computed over 1 year, (3) The number of monthly appointments actually scheduled.
Questionnaire study A questionnaire was developed which measured beliefs about testicular cancer concerning (a) its severity, (b) the chances of recurrence or spread, (c) the benefits of follow-up and (d) difficulties with coming for follow-up (Table I) . Items 2, 3, 7 and 9 were adapted from questions (in colloquial North American English) developed and tested in a number of large clinical studies in the USA (Leventhal et al., 1986; Stillman, 1977) . Items 2 and 3 were designed to show whether patients believed their disease was local or wide spread.
Patients were approached to give informed consent on their regularly scheduled clinic appointment. All patients in the chemotherapy group had completed their treatment. No patients refused to take part in the study.
Results
Chart review More than half of those treated by chemotherapy (57%) were 100% compliant with appointments and only a small proportion (14%) fell below 80% compliance. None of the surgery only group were 100% compliant, and 57% were less than 80% compliant. Patients treated with chemotherapy kept almost all (92.8%) of their appointments, while surgical patients kept only 77% (t = 3.52, d.f. = 20.8, P = 0.0021). Patients treated with chemotherapy were examined on the average of 10.0 of the 12 months. Surgery only patients were seen during an average of 8.36 months in the same 12 month period (t = 2.29, d.f. = 21.1, P = 0.032). Patients treated with chemotherapy were seen during more of the first 6 months than the group treated by surgery alone (means of 5.4 vs 4.4), but the difference is still significant during the second half of the 12 months after surgery (4.6 vs 4.0, t = 2.29, d.f. = 21.9, P = 0.032). Almost the same results are obtained when adherence to monthly visits is measured for a year after chemotherapy and compared with the year after orchidectomy for the surgery alone group (t = 2.37, d.f. = 21.1, P = 0.027). Surgery alone patients had a mean of 91% of the required appointments scheduled and chemotherapy patients had a mean of 85% (t = 0.56, d.f. = 22.6, P = 0.58).
Questionnaire study Only the results from questions with rating scales or forced choices are included here. Open ended questions generally produced unratable anecdotal answers. The 12 objective questions fell into four groups concerning perceptions of illness severity, susceptibility to relapse and the benefits and difficulties of the watch and wait protocol. Mean or modal choices for each treatment group are shown in Table I. Patients treated only by surgery did not think that they were any more likely to relapse than patients treated by chemotherapy. There was a nonsignificant trend for chemo- More of the patients treated by chemotherapy rated their disease as extremely dangerous than patients treated only by surgery (P = 0.0473). The two groups did not differ significantly in whether they saw their disease as local of widespread (P= 0.2638) on questions 2 and 3.
Although there was a trend for chemotherapy patients to choose answers suggesting they saw their disease as widespread, about half of the surgery alone patients also held this view.
Could any statistical relationship be shown between beliefs about the severity of the disease and perceptions of the difficulties of follow up? There is a trend for patients who did not see testicular cancer as dangerous to see coming for follow up as more of a nuisance, but the significance is borderline (P = 0.0578). The relationship between perceptions of the danger of the disease and the type of disease model was not significant (P = 0.70). Among those whom saw the disease as dangerous, however, twice as many believed their disease was widespread.
Discussion
The results of the chart review suggest that testicular cancer patients treated by surgery alone are less compliant than those treated with chemotherapy. Given the small sample sizes these results clearly require further validation in a prospective study with a larger sample size. However, the questionnaire study with a separate sample of patients and a different method also confirms that surgical patients saw follow-up as a nuisance. The greater tendency of chemotherapy patients to come for follow-up is apparent not only during their chemotherapy, but also persists long past the end of chemotherapy. Problems with compliance cannot reflect possible aversive effects of treatment (depression, emotional upset and sexual dysfunction) since these would be expected to be worse for patients receiving chemotherapy.
The questionnaire study sheds some light on the difference in compliance between the two groups. Chemotherapy patients tended to see their disease as more dangerous than surgical patients. Of course, chemotherapy patients did start with more advanced disease and the unpleasantness of the chemotherapy would be expected to reinforce disease severity. However, the low estimate of danger by surgical patients is very unrealistic because their chance of relapse is much higher.
In this study, the perceived danger of the disease is not closely related to whether the patient believed the disease was localised or widespread (unlike the findings of Leventhal et of lymph node dissection or prophylactic radiation therapy. However, the success of this policy is critically dependent on patient compliance and it seems that this can only be improved by better patient education. Our future efforts will be directed at developing and evaluating tools to achieve this.
